Good summary Gareth, key takeaways for me were:
- Big TAM.
- Unique value proposition with little or no competition for some uses.
- Significant Clinical Interest
EMvision Research Notes, page-2597
-
- There are more pages in this discussion • 142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.09 |
Change
0.070(3.47%) |
Mkt cap ! $178.7M | |||
| Open | High | Low | Value | Volume |
| $2.03 | $2.09 | $2.03 | $42.61K | 20.71K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $2.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.10 | 3000 | 1 |
View Market Depth
| Last trade - 15.52pm 18/10/2024 (20 minute delay) ? |
| EMV (ASX) Chart |